VIRAL GENETICS, INC


Sep 16, 09

NEW STORY
17:31 ET Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference

 
Aug 26, 09

17:07 ET Viral Genetics Completes Second Major Debt Conversion

 
15:22 ET Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases

 
Aug 11, 09

16:23 ET Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium

 
Aug 07, 09

06:00 ET Viral Genetics Creates Subsidiary to Develop Cancer Therapy

 
Jul 13, 09

06:00 ET Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances

 
Jul 08, 09

20:53 ET Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website

 
May 21, 09

21:12 ET Viral Genetics Has Option Under Issued Key Patent for Cancer Drug

 
May 20, 09

20:44 ET CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.

 
Mar 13, 07

09:00 ET Viral Genetics Restructures Convertible Debentures

 
Jan 09, 07

11:30 ET Viral Genetics Identifies Crucial Peptides for Potential HIV/AIDS Drug

 
Dec 07, 06

09:00 ET Viral Genetics to Present at New York Society of Security Analysts 10th Annual Biotech and Specialty Pharmaceuticals Conference

 
Nov 02, 06

10:00 ET Viral Genetics to Present at Rodman & Renshaw Healthcare Conference and The PIPEs Conference

 
Oct 30, 06

09:00 ET Viral Genetics' AIDS Study Results to Be Presented at Institute of Human Virology's 2006 International Meeting

 
Oct 03, 06

11:00 ET Viral Genetics Adds Two Harvard Specialists to Scientific Advisory Board

 
Sep 26, 06

11:00 ET Viral Genetics to Exhibit at ICAAC

 
11:00 ET Viral Genetics to Present at EdgeWater Investment Conference

 
Sep 25, 06

12:09 ET Viral Genetics Appoints Dr. Eric S. Rosenberg Chairman of Scientific Advisory Board

 
Sep 11, 06

11:00 ET Viral Genetics Expands Communications to Mark US Development Program

 
Aug 11, 06

12:44 ET Viral Genetics' AIDS Study Results at XVI International AIDS Conference

 
Jul 24, 06

11:00 ET Viral Genetics' AIDS Study Yields Encouraging Results

 
Jun 01, 05

13:10 ET Dr. Louis W. Sullivan, M.D., Joins Scientific and Medical Advisory Board of Viral Genetics, Inc.

 
May 25, 05

14:38 ET Arthur J. Ammann, M.D., Joins Board of Directors of Viral Genetics, Inc.

 
May 23, 05

13:43 ET Viral Genetics, Inc. Files 1st Quarter Report and Invites Investors to Participate in Conference Call

 
Apr 07, 05

16:33 ET Viral Genetics, Inc. 'VRAL,' Files Annual Report and Invites Investors to Participate in Conference Call

 
Mar 15, 05

15:15 ET Viral Genetics, Inc. Completes Patient Enrollment for South African Phase III Trial of VGV-1 for the Treatment of HIV-1

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2009 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.